Alzheimer's and Parkinson's disease therapies in the clinic

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent neurodegenerative diseases, affecting millions and costing billions each year in the United States alone. Despite tremendous progress in developing therapeutics that manage the symptoms of these two diseases, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopade, Puja, Chopade, Neha, Zhao, Zongmin, Mitragotri, Samir, Liao, Rick, Chandran Suja, Vineeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842041/
https://www.ncbi.nlm.nih.gov/pubmed/36684083
http://dx.doi.org/10.1002/btm2.10367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842041/
https://www.ncbi.nlm.nih.gov/pubmed/36684083
http://dx.doi.org/10.1002/btm2.10367

Ejemplares similares